AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Bid | 15.75 |
Market Cap | 1.36B |
Revenue (ttm) | - |
Net Income (ttm) | - |
EPS (ttm) | 1.83 |
PE Ratio (ttm) | 8.79 |
Forward PE | n/a |
Analyst | Hold |
Ask | 16.25 |
Volume | 500,558 |
Avg. Volume (20D) | 979,932 |
Open | 16.09 |
Previous Close | 15.97 |
Day's Range | 15.73 - 16.20 |
52-Week Range | 14.87 - 26.80 |
Beta | undefined |
About INMD
InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin ...
Analyst Forecast
According to 6 analyst ratings, the average rating for INMD stock is "Hold." The 12-month stock price forecast is $25, which is an increase of 55.38% from the latest price.
Next Earnings Release
Analysts project revenue of $117.83M, reflecting a -7.06% YoY shrinking and earnings per share of 0.59, making a -16.90% decrease YoY.
1 month ago · seekingalpha.com
InMode: Product Origination And Undervaluation Make The Stock A BuyInMode Ltd. demonstrates impressive net income growth from non-invasive surgical products, with new platforms Define and Envision expected to drive future business growth. The company's innovative tec...